Myung In Pharmaceutical LTD. (KRX:317450)
South Korea flag South Korea · Delayed Price · Currency is KRW
43,800
+2,300 (5.54%)
At close: Jun 9, 2026

KRX:317450 Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
37,84531,79232,89734,44918,25152,967
Short-Term Investments
484,253477,901227,399153,080124,43467,786
Cash & Short-Term Investments
522,098509,692260,296187,529142,686120,753
Cash Growth
100.58%95.81%38.80%31.43%18.16%70.83%
Accounts Receivable
63,27963,65160,77158,14756,78356,688
Other Receivables
6,0855,0553,4923,7112,7102,138
Receivables
69,36368,87064,43362,02059,64659,033
Inventory
63,01964,10860,34356,27747,88046,732
Prepaid Expenses
448.85538.02510.71434.13533.52243.22
Other Current Assets
1,694100.97225.491,32972.68176.49
Total Current Assets
656,624643,309385,809307,589250,818226,938
Property, Plant & Equipment
129,181118,51399,25999,309103,706110,187
Long-Term Investments
14,89110,21910,78328,60824,2426,804
Other Intangible Assets
6,1755,520713.02710.9711.01711.69
Long-Term Accounts Receivable
1,8571,9242,2312,0392,3002,545
Long-Term Deferred Tax Assets
-----4.51
Other Long-Term Assets
62,04761,94382,71783,11989,52882,344
Total Assets
870,775841,675581,692521,590471,556429,760
Accounts Payable
8,2036,3018,2982,3972,1292,245
Accrued Expenses
996.011,2071,3271,4251,2962,290
Current Portion of Leases
958.541,1751,5281,7271,7391,329
Current Income Taxes Payable
13,35711,45812,38912,94911,47213,494
Current Unearned Revenue
14.6717.32----
Other Current Liabilities
50,68526,02621,05920,68618,45820,374
Total Current Liabilities
74,21446,18444,60239,18435,09339,732
Long-Term Leases
331.57211.161,1722,1603,2064,281
Long-Term Unearned Revenue
175.657.2970.23115.85161.47-
Pension & Post-Retirement Benefits
-----668.61
Long-Term Deferred Tax Liabilities
74.531.661,4395,3276,6846,605
Other Long-Term Liabilities
1,501892.392,5892,4892,4322,382
Total Liabilities
76,29747,29749,87149,27647,57753,668
Common Stock
7,3007,3005,6005,6005,6005,600
Additional Paid-In Capital
192,082192,082----
Retained Earnings
603,201602,371533,269471,701421,245373,297
Comprehensive Income & Other
-8,106-7,375-7,049-4,988-2,866-2,805
Shareholders' Equity
794,478794,378531,821472,314423,979376,092
Total Liabilities & Equity
870,775841,675581,692521,590471,556429,760
Total Debt
1,2901,3862,7003,8874,9455,609
Net Cash (Debt)
520,808508,306257,596183,642137,740115,143
Net Cash Growth
102.18%97.33%40.27%33.32%19.63%80.64%
Net Cash Per Share
40149.0841931.8422998.4816396.6212298.2510280.65
Filing Date Shares Outstanding
14.614.611.211.211.211.2
Total Common Shares Outstanding
14.614.611.211.211.211.2
Working Capital
582,409597,125341,207268,406215,724187,206
Book Value Per Share
54419.3054409.4647483.9842170.8937855.2833579.64
Tangible Book Value
788,303788,858531,108471,603423,268375,380
Tangible Book Value Per Share
53996.3154031.3847420.3142107.4137791.8033516.10
Land
39,46639,46639,46739,08937,09836,955
Buildings
59,27359,27359,17959,29159,02058,923
Machinery
100,56798,43095,86590,30487,40385,970
Construction In Progress
41,63330,9165,2361,374258.5286.44